F
Fabrizio Calliada
Researcher at University of Pavia
Publications - 136
Citations - 8248
Fabrizio Calliada is an academic researcher from University of Pavia. The author has contributed to research in topics: Elastography & Contrast-enhanced ultrasound. The author has an hindex of 33, co-authored 132 publications receiving 7003 citations. Previous affiliations of Fabrizio Calliada include Sapienza University of Rome.
Papers
More filters
Journal ArticleDOI
EFSUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography. Part 1: Basic Principles and Technology
Jeffrey C. Bamber,David O. Cosgrove,Christoph F. Dietrich,Jeremie Fromageau,Jörg Bojunga,Fabrizio Calliada,Cantisani,Jean Michel Correas,Mirko D'Onofrio,E. E Drakonaki,Mathias Fink,Mireen Friedrich-Rust,Odd Helge Gilja,Roald Flesland Havre,Christian Jenssen,Andrea Klauser,R Ohlinger,Adrian Saftoiu,F Schaefer,Ioan Sporea,Fabio Piscaglia +20 more
TL;DR: The technical part of these Guidelines and Recommendations provides an introduction to the physical principles and technology on which all forms of current commercially available ultrasound elastography are based.
Journal ArticleDOI
EFSUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography.Part 2: Clinical Applications
David O. Cosgrove,Fabio Piscaglia,Jeffrey C. Bamber,Jörg Bojunga,Jean Michel Correas,Odd Helge Gilja,Andrea Klauser,Ioan Sporea,Fabrizio Calliada,Cantisani,Mirko D'Onofrio,E. E Drakonaki,Mathias Fink,Mireen Friedrich-Rust,Jeremie Fromageau,Roald Flesland Havre,Christian Jenssen,R Ohlinger,Adrian Saftoiu,F Schaefer,Christoph F. Dietrich +20 more
TL;DR: The clinical part of these Guidelines and Recommendations produced under the auspices of the European Federation of Societies for Ultrasound in Medicine and Biology EFSUMB assesses the clinically used applications of all forms of elastography, stressing the evidence from meta-analyses and giving practical advice for their uses and interpretation.
Journal ArticleDOI
Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - Update 2008
Michel Claudon,David O. Cosgrove,T. Albrecht,Luigi Bolondi,M. Bosio,Fabrizio Calliada,J. M. Correas,Kassa Darge,Christoph F. Dietrich,Mirko D'Onofrio,David H. Evans,Carlo Filice,L. Greiner,K. Jäger,N. de Jong,Edward Leen,Riccardo Lencioni,D. Lindsell,Alberto Martegani,S. Meairs,Christian Pállson Nolsøe,Fabio Piscaglia,Paolo Ricci,G. Seidel,Bjørn Skjoldbye,Luigi Solbiati,L. Thorelius,François Tranquart,H. P. Weskott,T. Whittingham +29 more
TL;DR: EFSUMB study group M. Claudon, D. Cosgrove, T. Tranquart, L. Thorelius, and H. Whittingham study group L. de.
Journal ArticleDOI
The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version)
Paul S. Sidhu,Vito Cantisani,Christoph F. Dietrich,Odd Helge Gilja,Adrian Saftoiu,Eva Bartels,Michele Bertolotto,Fabrizio Calliada,Dirk-André Clevert,David O. Cosgrove,Annamaria Deganello,Mirko D'Onofrio,Francesco Maria Drudi,Simon Freeman,Chris J Harvey,Christian Jenssen,Ernst Michael Jung,Andrea Klauser,Nathalie Lassau,Maria Franca Meloni,Edward Leen,Carlos Nicolau,Christian Pállson Nolsøe,Fabio Piscaglia,Francesco Prada,H. Prosch,Maija Radzina,Luca Savelli,Hans Peter Weskott,Hessel Wijkstra +29 more
TL;DR: The updated version of the EFSUMB guidelines on the application of non-hepatic contrast-enhanced ultrasound (CEUS) deals with the use of microbubble ultrasound contrast outside the liver in the many established and emerging applications.
Journal ArticleDOI
Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease
Rachele Ciccocioppo,Maria Ester Bernardo,Adele Sgarella,Rita Maccario,Maria Antonietta Avanzini,C. Ubezio,Antonella Minelli,Costanza Alvisi,Alessandro Vanoli,Fabrizio Calliada,Paolo Dionigi,Cesare Perotti,Franco Locatelli,Gino Roberto Corazza +13 more
TL;DR: Locally injected MSCs represent a feasible, safe and beneficial therapy in refractory fistulising Crohn's disease and have been proven to affect mucosal T cell apoptotic rate.